Presentationer
2026
- CEO Anders Haegerstrand presents at Biostock’s event Investing in Life Science, Stockholm September 22, 2026 (Eng)
- Q2-2026 Financial report and business update – Webcast with Investor Studios – CEO Anders Haegerstrand (swe)
- CEO Anders Haegerstrand presenting at Aktiedagarna Stockholm, 10 June 2026 (swe)
- CEO Anders Haegerstrand presenting at Biostock Global Forum 2026, 21 May 2026 (eng)
- CEO Anders Haegerstrand presenting at the Life Science Investor Conference, Økonomisk Ugebrev A/S, Copenhague, April 22, 2026 (eng)
- CEO Anders Haegerstrand presenting at Redeye Healthcare Day, 15 April, 2026 (eng)
2024
- CSO/CMO Anna Frostegård presenting at Redeye Technology & Life Science day, 3 December 2024 (eng)
- CEO Anders Haegerstrand presenting at BioStock Life Science Summit in Lund, 21 November 2024 (eng)
- CEO Anders Haegerstrand presenterar på Redeye Investor forum i Göteborg, 7 november 2024 (swe)
- Biostock Vator Securities event – 5 min CEO interview with Anders Haegerstrand, 12 September 2024 (eng)
- Biostock Vator Securities Event – Investing in Life Science 2024 – From Seed to Success, 12 September 2024
- Biostock interview on topline data with our CEO Anders Haegerstrand & CSO/CMO Anna Frostegård, 27 August 2024
- Interview at Redeye on topline data with our CEO Anders Haegerstrand & CSO/CMO Anna Frostegård, 22 August 2024
- CEO Anders Haegerstrand & CSO/CMO Anna Frostegård presenterar på Redeye Growth Day 2024, 31 maj 2024
- CSO/CMO Anna Frostegård presenterar hos Redeye, 16 maj 2024
- CSO/CMO Anna Frostegård & CEO Anders Haegerstrand intervju om sista patienten behandlad i Annexins RVO studie – lovande effektsignaler och inga säkerhetsproblem, 29 april 2024
